NICE relents and okays Akcea’s rare disease drug Waylivra for NHS usePatients with the rare disease familial chylomicronemia syndrome (FCS) will be able to access treatment with Akcea’s Waylivra Share XNICE relents and okays Akcea’s rare disease drug Waylivra for NHS usehttps://pharmaphorum.com/news/nice-relents-and-okays-akceas-rare-disease-drug-waylivra-for-nhs-use/
BioNTech, Lilly shore up manufacturing capacity for their COVID-19 medsWith vaccines and drugs for COVID-19 now in late-stage development, companies are moving swiftly to lay down the Share XBioNTech, Lilly shore up manufacturing capacity for their COVID-19 medshttps://pharmaphorum.com/news/biontech-lilly-shore-up-manufacturing-capacity-for-their-covid-19-meds/
Price cut wins NICE OK for AZ’s Tagrisso in untreated lung cancerUK cost-effectiveness watchdog NICE has changed its stance on AstraZeneca’s Tagrisso as a first-line therapy for non-small cell Share XPrice cut wins NICE OK for AZ’s Tagrisso in untreated lung cancerhttps://pharmaphorum.com/news/price-cut-wins-nice-ok-for-azs-tagrisso-in-untreated-lung-cancer/
After a nay from NICE, Scotland says aye to J&J’s SpravatoNHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug Share XAfter a nay from NICE, Scotland says aye to J&J’s Spravatohttps://pharmaphorum.com/news/after-a-nay-from-nice-scotland-says-aye-to-jjs-spravato/
COVID-19 vaccine could be ready in time for US electionsHealth officials in the US have been told to prepare for a COVID-19 vaccine to be ready by Share XCOVID-19 vaccine could be ready in time for US electionshttps://pharmaphorum.com/news/covid-19-vaccine-could-be-ready-in-time-for-us-elections/
NICE rejects Janssen’s depression spray Spravato for second timeNICE has rejected regular NHS funding for Janssen’s depression spray Spravato (esketamine) for a second time, although the Share XNICE rejects Janssen’s depression spray Spravato for second timehttps://pharmaphorum.com/news/nice-rejects/
Canada signs deals for J&J, Novavax COVID vaccinesThe Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates. Share XCanada signs deals for J&J, Novavax COVID vaccineshttps://pharmaphorum.com/news/canada-signs-deals-for-jj-novavax-covid-vaccines/
Novo launches type 2 diabetes pill in UK after NICE waives reviewNovo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE Share XNovo launches type 2 diabetes pill in UK after NICE waives reviewhttps://pharmaphorum.com/news/novo-launches-type-2-diabetes-pill-in-uk/
FDA hands Cassiopea its first approval, for acne drug WinleviItalian biotech Cassiopea has won US approval for Winlevi, a topical therapy it says is the first new Share XFDA hands Cassiopea its first approval, for acne drug Winlevihttps://pharmaphorum.com/news/fda-hands-cassiopea-its-first-approval-for-acne-drug-winlevi/
